Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity

Search this Article

Author(s)

    • MORIWAKI Kenta
    • Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine
    • OKUDO Kumiko
    • Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine
    • HARAGUCHI Naotsugu
    • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
    • SAWAKI Hiromichi
    • Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology
    • NARIMATSU Hisashi
    • Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology
    • TANEMURA Masahiro
    • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
    • ISHII Hideshi
    • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
    • MORI Masaki
    • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
    • MIYOSHI Eiji
    • Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine

Journal

  • Cancer science

    Cancer science 102(6), 1164-1170, 2011-06-10

References:  46

Codes

  • NII Article ID (NAID)
    10029294388
  • NII NACSIS-CAT ID (NCID)
    AA11808050
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    13479032
  • Data Source
    CJP 
Page Top